http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005032555-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ceabb2ec048d4663d598ad4da154b15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac2c17e532220d91aca9a28ef60f178b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_135adcc9c90c975248b9b2f8238ce90a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a230f8942aedf7c6cb9cebc1e447a5ef
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f85a326b13e45b7af087f5216d2dcef0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68645b67746b8f4c961795192c657820
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fac6de902a52796a7c5b5e944d51041
publicationDate 2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005032555-A3
titleOfInvention Pharmaceutical combinations of hydrocodone and naltrexone
abstract Disclosed is a pharmaceutical composition comprising from about 5 to about 20 mg of hydrocodone or a pharmaceutically acceptable salt thereof and from 0.055 to about 0.56 mg naltrexone or pharmaceutically acceptable salt thereof
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916195-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9457005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125868-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9107837-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248123-B2
priorityDate 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003031712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6228863-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6375957-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395283

Total number of triples: 35.